Rocket Pharmaceuticals Beats Expectations in Q3

Markets & Money Today | 2 Min News | The Daily News Now! - En podkast av The Daily News Now! - Tirsdager

Prøv Podimo gratis i hele 60! dager!

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

 Reklame
Podcast artwork

Kategorier:

Forretning

Rocket Pharmaceuticals reported a Q3 loss of $50.3M, or $0.45 per share, surpassing analysts expectations of $0.48 per share. This positive financial performance provides a clearer picture of the companys health in the pharmaceutical sector.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site